Related by context. All words. (Click for frequent words.) 62 neuropsychological assessment 62 neuropsychological tests 61 audiometric 61 neurosensory 61 polysomnographic 60 APOE genotype 60 EEG recordings 60 Cardiorespiratory fitness 60 polysomnography PSG 60 neuropsychological evaluations 59 perfusion CT 59 meta regression 59 Polysomnography 59 GH deficiency 59 sociodemographic characteristics 59 overnight polysomnography 58 CaPSURE 58 electrophysiologic 58 comorbid anxiety 58 neuropsychological 58 premorbid 58 electroencephalograms 58 diagnosing ADHD 58 psychomotor skills 57 schizophrenia schizoaffective disorder 57 exhaled nitric oxide 57 Electrophysiological 57 Symptom severity 57 tumor histology 57 Sociodemographic 57 Neuropsychological 57 Lewy bodies DLB 57 electrocardiographs 57 alpha1 antitrypsin deficiency 57 neurocognitive function 57 depressive symptomatology 57 conditional logistic regression 57 Multivariable logistic regression 57 polysomnogram 57 sociodemographic factors 57 anthropometric measurements 57 EQ 5D 57 FDG PET scans 57 ski lls 56 psychosocial variables 56 inhaled corticosteroid therapy 56 pharmacokinetic pharmacodynamic 56 HRQL 56 MSLT 56 Logistic regression 56 Neurocognitive 56 comorbid depression 56 actigraphy 56 micronutrient supplementation 56 audiometry 56 convergent validity 56 neurophysiologic 56 nonpsychotic 56 pharmacodynamic parameters 56 transcranial Doppler ultrasound 56 fetal chromosomal abnormalities 56 BPS IC 56 aMCI precursor 56 Prognostic factors 56 Electroencephalography 56 SensiGene 56 autopsied brains 56 bispectral index BIS 56 Primary endpoints 56 Multiple logistic regression 56 EDEMA3 trial 56 EGFR mutation status 56 Cognitive behavioral 56 multiple logistic regression 56 nonepileptic seizures 56 intratympanic 56 neuromotor 56 #q# deletion syndrome 56 reproductive endocrine 56 Phenylketonuria PKU 56 neuropsychological impairments 55 urodynamic 55 semistructured interviews 55 affective psychosis 55 resting ECG 55 neuro cognitive 55 chromium picolinate supplementation 55 audiologic 55 Multivariate logistic regression 55 brachial artery flow 55 poststroke 55 diagnostic laparoscopy 55 pharmacogenetic tests 55 QEEG 55 glycosylated hemoglobin levels 55 prognostic indicators 55 haematologic 55 anthropometric measures 55 posttest 55 comorbid psychiatric disorders 55 congenital toxoplasmosis 55 FFR measurements 55 daytime somnolence 55 Secondary efficacy endpoints 55 neurocognitive functioning 55 DSM IV diagnoses 55 retrospective cohort 55 TF CBT 55 Tasigna prolongs 55 guideline concordant 55 bronchial hyperresponsiveness 55 venlafaxine XR 55 Functional neuroimaging 55 attention-deficit/hyperactivity 55 sociodemographic 55 radiographic outcomes 55 ADAS Cog 55 Child Behavior Checklist 55 Comorbidity 55 preintervention 55 ADCS CGIC 55 biostatistical analysis 55 VCUG 55 multivariate analyzes 55 pressure monitoring ABPM 55 AGHD 55 pharmacogenetic testing 55 affective disorders 55 hemodynamic measurements 54 OnDose TM 54 clinically meaningful improvement 54 serum lipid levels 54 exhaled nitric oxide eNO 54 eTag assays 54 neuro developmental 54 maturational 54 psychosocial functioning 54 sociodemographics 54 acute mania 54 opioid naive 54 neurocognitive impairment 54 perinatal outcomes 54 neurobehavioral 54 neurodevelopmental outcomes 54 underwent coronary angiography 54 cerebrospinal fluid biomarkers 54 spirometric 54 audiological 54 euthymic patients 54 neuro psychological 54 schizophreniform disorder 54 Phase IIb III 54 sonographic diagnosis 54 Intravenous immunoglobulin 54 CA9 SCAN 54 constipation OIC 54 prespecified secondary 54 Tumor Response 54 Limperopoulos 54 Health Assessment Questionnaire 54 pharmacodynamic markers 54 ophthalmoscopy 54 meta analytic review 54 coronary CTA 54 androgen depletion 54 Negative Symptoms 54 dysbindin gene 54 HRQOL 54 Erectile function 54 antidiabetic medication 54 cognitive domains 54 tissue oxygenation 54 Stanford Binet 54 PIB PET 54 opioid dependent 54 psychometric properties 54 salivary cortisol 54 prognostic variables 54 neuropsychological functioning 54 somatization disorder 54 PREVU * LT 54 metabolite concentrations 54 Signal X6 54 multicentre prospective 54 clinically meaningful improvements 54 perceptual reasoning 54 dietary questionnaires 54 syndromic 54 Meta analyzes 54 endocrinologic 54 limiting generalizability 54 hsCRP levels 54 radiographic examinations 54 ELBW infants 54 psychiatric comorbidities 54 retrospective observational study 54 subthreshold depression 54 antipsychotic prescribing 54 glycosylated hemoglobin HbA1c 54 comorbid disorders 54 psychophysiological 54 CYP#D# genotype 54 pharmacodynamic PD 54 CONCERTA ® 54 eNO 54 euthymic 54 ADEAR Center 54 microalbumin 54 EEG biofeedback 54 Multivariate analysis 54 genotype phenotype 54 orally inhaled migraine 54 neuro musculoskeletal 53 attain statistical significance 53 subjective sleepiness 53 somatic symptoms 53 multivariate regression analysis 53 mechanistic studies 53 MBHO 53 vivo preclinical 53 FDG PET imaging 53 shorter telomere length 53 Neuropsychiatric Inventory NPI 53 physiological parameters 53 recombinant PSMA vaccine 53 observational cohort study 53 Polysomnographic 53 epoetin alpha 53 Wechsler Memory 53 haematological 53 TAXUS ARRIVE 53 orofacial pain 53 hematopoietic cancers 53 predictive validity 53 nondemented 53 cluster randomized controlled 53 CINQUIL 53 functional MRIs 53 retrospectively analyzed 53 PCWP 53 thrombophilia 53 prenatally diagnosed 53 NHAMCS 53 mild cognitive impairments 53 electrocardiography ECG 53 procedural sedation 53 radiation dosimetry 53 BioMAP 53 prospectively enrolled 53 Regression analyzes 53 neuromuscular electrical stimulation 53 Edinburgh Postnatal Depression 53 lipid lowering medication 53 intraclass correlation coefficients 53 multivariable analysis 53 NIHSS score 53 HAQ DI 53 psychiatric outpatients 53 Univariate 53 pathophysiological mechanisms 53 CARE HF 53 psychoeducational 53 Injury Severity Score 53 Severe Primary IGFD 53 CT perfusion 53 antiretroviral naïve 53 perfusion abnormalities 53 proton MR spectroscopy 53 sociodemographic variables 53 pharmacologic treatments 53 multiple linear regression 53 intradermal injections 53 decompensated cirrhosis 53 DNA methylation patterns 53 erection hardness 53 inflammatory biomarkers 53 thorough QT 53 Main Outcome Measure 53 Secondary endpoints include 53 methacholine challenge 53 impaired insulin secretion 53 longitudinal cohort 53 HRQoL 53 clinico pathological 53 generalized estimating 53 diabetic polyneuropathy 53 conducted retrospective cohort 53 neuro stimulation 53 cytogenic 53 psychiatric comorbidity 53 Wechsler Adult 53 polysomnography 53 logistic regression analyzes 53 comorbid diagnoses 53 cortex thickness 53 DLQI 53 EKG electrocardiogram 53 electroencephalograph EEG 53 ECLS 53 preadmission 53 CYP#D# inhibitor 53 transrectal ultrasound guided 53 biobehavioral 53 prospective observational studies 53 peri natal 53 prospective observational cohort 53 neurobehavioural 53 LungAlert TM 53 de novo AML 53 transthoracic echocardiography 53 nucleic acid isolation 53 functional MRI fMRI 53 Wisconsin Sleep Cohort 53 miRNA profiling 53 PORxin TM platforms 53 neurodevelopmental outcome 53 BMI z 53 neuro developmental disorders 53 intraobserver 53 abnormal cytology 53 #q# deletion 53 MDCT scans 53 SIMPADICO 53 electroencephalographic 53 warfarin dosage 52 Skin sterol 52 budesonide MMX Phase III 52 Longitudinal studies 52 hyperphenylalaninemia HPA due 52 thyroid carcinoma 52 perfusion MRI 52 Treatment Outcome 52 posttransplant 52 physiologic responses 52 hormone receptor status 52 neuroleptic 52 pretreatment serum 52 noncognitive 52 binary logistic regression 52 obstetric ultrasound 52 prenatal exposures 52 endocrine dysfunction 52 histological subtype 52 Angela Genge 52 corticosteroid dose 52 echocardiographic parameters 52 Univariate analysis 52 eculizumab therapy 52 internalizing disorders 52 perinatal asphyxia 52 tonsillar hypertrophy 52 affective psychoses 52 transient insomnia 52 OBPM 52 LAB CGRP 52 Methods Retrospective 52 multivariate logistic regression 52 CIBIC + 52 deCODE AF TM 52 nonpsychiatric 52 acetabular fractures 52 REMINYL ® 52 blinded randomized controlled 52 genomewide 52 histologically proven 52 left ventricular diastolic 52 autonomic dysfunction 52 ragweed allergic 52 relapsed MM 52 comorbid psychiatric 52 near infrared spectroscopic 52 neuropathologic 52 COMT genotype 52 antidiabetic medications 52 chi squared 52 clinicopathological features 52 Quantitative EEG 52 dietary carbohydrate 52 buprenorphine implants 52 clinical pharmacology studies 52 Persistent Sleep 52 liver histology 52 Multivariate analyzes 52 Hill Rom enhancing 52 chromosomal anomaly 52 EXPLORE Xa 52 Subgroup analysis 52 esophageal pH 52 transcranial Doppler 52 lymphocyte count 52 ER CHOP 52 MMSE score 52 therapeutic radiopharmaceuticals 52 LQTS 52 Ultrasonographic 52 prospective longitudinal 52 NIR spectroscopy 52 waist circumference WC 52 Requires Bachelor Degree 52 multivariable analyzes 52 ultrasonographic examination 52 bioprosthetic valve 52 periodically reassessed 52 genotypic resistance 52 intravenous tPA 52 modifying metabolic pathways 52 nonpharmacologic 52 GAMMAGARD 52 biostatistical 52 LDH lactate dehydrogenase 52 habitual snoring 52 fetal oxygen saturation 52 CPAP adherence 52 Global Impression CGI 52 telerehabilitation 52 obstetrical ultrasound 52 WOMAC pain 52 clinical neurophysiology 52 THIS STUDY analyzed 52 microRNA profiling 52 Non inferiority 52 BEXXAR Therapeutic Regimen 52 NMES 52 daytime alertness 52 multicenter Phase II 52 basal bolus regimen 52 PROMETA protocols 52 Socio demographic 52 Logistic regression analyzes 52 OVA1 ® 52 noninvasive outpatient 52 therapy CBT 52 amnestic MCI 52 subclinical atherosclerosis 52 bivariate analyzes 52 QOPI 52 preclinical pharmacology 52 bronchopulmonary dysplasia BPD 52 phase IIIb 52 carotid IMT 52 endophenotypes 52 intravenous methylnaltrexone 52 Echocardiographic 52 juvenile idiopathic arthritis 52 pharmacokinetic parameters 52 ambulatory inpatient 52 circadian rhythm disorders 52 gallium nitrate 52 antiepileptics 52 OSAHS 52 PDE# inhibitors 52 genomewide association study 52 careHPV 52 abnormal lipid 52 antenatal depression 52 NPM1 mutation 52 cerebral angiography 52 Fasting glucose 52 saline infusion 52 endocrine diseases 51 Randomized controlled 51 biochemical abnormalities 51 functional neuroimaging 51 visceral metastases 51 mild renal insufficiency 51 neurological impairments 51 poststroke depression 51 DNA methylation markers 51 PGD PGS 51 mania hypomania 51 hippocampal volumes 51 prospectively stratified 51 State Exam MMSE 51 schizoaffective 51 nasal airflow 51 Fibromyalgia Impact Questionnaire 51 Comorbidities 51 schizophrenia bipolar disorders 51 transient elastography 51 transrectal ultrasound 51 parous women 51 CHAMPION PCI 51 Scale PANSS 51 For Michele Burkhammer 51 idiopathic intracranial hypertension 51 Zemplar Capsules 51 colonoscopic 51 fetal aneuploidy 51 glycated hemoglobin levels 51 STEP BD 51 colon rectal 51 prognostic biomarker 51 subscale scores 51 PRIMO CABG 51 cortical stimulation 51 Multiple linear regression 51 engineered urethras 51 esophageal manometry 51 Current Controlled Trials 51 enteroviral infection 51 pharmacokinetic interaction 51 cerebral oximetry 51 adenotonsillectomy 51 Randomised controlled trial 51 exploratory endpoints 51 hydroxy vitamin D 51 euglycemic clamp 51 EORTC QLQ C# 51 HEDIS R 51 toxicologic 51 neurocognitive deficits 51 KRAS mutation status 51 Prodarsan R 51 abdominal ultrasounds 51 #q#.# deletion syndrome 51 histologic subtype 51 d dimer 51 PLAC test 51 CIMZIA TM certolizumab pegol 51 HIV HCV coinfected 51 T1DM 51 antiangiogenic therapy 51 Change PGIC 51 Renal Cell Carcinoma RCC 51 aMCI 51 internalizing behaviors 51 prospectively evaluated 51 Juvenile Idiopathic Arthritis 51 autistic traits 51 catheter ablations 51 VaD 51 psychotherapeutic treatments 51 calculated creatinine clearance 51 subscales 51 PLX STROKE targeting 51 metaanalysis 51 opioid naïve 51 Testosterone deficiency 51 TriGrid 51 bronchial lavage 51 CIBIC plus 51 Alzheimer Disease Cooperative 51 coagulation abnormalities 51 semiquantitative 51 electrodiagnostic 51 psychoeducation 51 CSF biomarkers 51 InfoScriber 51 Logistic regression analysis 51 Hp2 2 51 pulmonary artery hypertension 51 urine dipstick 51 skin sterol 51 Sentinel Lymph Node Biopsy 51 amnestic mild cognitive impairment 51 code Cu AA# 51 clefting 51 psychopharmacological 51 peak VO2 51 antioxidant supplementation 51 Interactive Metronome 51 endocrinological 51 ante partum 51 metabolic parameters 51 ELISA assay 51 atypical neuroleptics 51 CORE OM 51 neurocognitive 51 neuropsychologists 51 meta analytic 51 pretransplant 51 retest reliability 51 HPV genotyping 51 presurgical 51 Diabetic Foot Ulcer 51 cerebral oxygenation 51 pediatrics psychiatry 51 Charlson Comorbidity Index 51 Attention-Deficit/Hyperactivity Disorder ADHD 51 SRBD 51 transvaginal sonography 51 gait disturbance 51 pregnancy lactation 51 chest radiographs 51 fetal echocardiogram 51 Preoperatively 51 randomized controlled trials RCTs 51 immunosuppression therapy 51 multi infarct dementia 51 deCODE ProstateCancer TM 51 abnormal Pap smear 51 Oncotype DX Recurrence Score 51 creatinine levels 51 GBA mutations 51 electrocardiograms ECGs 51 cardio respiratory fitness 51 wrist actigraphy 51 undergoing coronary angiography 51 voiding dysfunction 51 plasma pharmacokinetics 51 intracerebral haemorrhage 51 Urinalysis 51 Netherlands Cohort Study 51 endoscopic examinations 51 longitudinal cohort study 51 CeaProve R 51 MATRICS 51 preclinical efficacy 51 et al #a 51 SGRQ 51 flow cytometric 51 neuropathological 51 SF #v# 51 Phase IIIb study 51 FDG-PET/CT 51 Edge STudy 51 hemodynamic parameters 51 operable breast cancer 51 rALLy trial 51 patientswith 51 bioavailable testosterone 51 hypertension diabetes mellitus 51 smoldering myeloma 51 HSCT 51 Abbott ARCHITECT 51 postintervention 51 CT urography 51 albumin excretion 51 serum concentrations 51 CLBP 51 enzyme metabolizes 51 Neuropsychiatric Inventory 51 cardio metabolic 51 HDL Selective Delipidation 51 anthropometric 51 renal biopsy 51 esophageal reflux 51 perfusion imaging 51 diagnostic angiography 51 thyroid deficiency 51 TPMT 51 prospectively defined 51 psychiatric morbidity 51 Genetic variants 51 HER2 overexpression 51 hemoglobin hematocrit 51 overactive bladder symptoms 51 MGd 51 stimulated insulin secretion 51 EEG abnormalities 51 laparoscopic bariatric surgery 50 microsatellite instability 50 PERMP 50 multivitamin supplementation 50 Framingham Offspring 50 clomipramine 50 neuro radiologists 50 post natally 50 semistructured interview 50 diagnostic prognostic 50 treating psychiatric disorders 50 telomere lengths 50 double blinded randomized 50 activated partial thromboplastin 50 cardiac perfusion 50 intracranial stenosis 50 impair cognitive 50 maternal serum 50 Neurobehavioral 50 potential confounders 50 multivariable Cox 50 pediatric bipolar disorder 50 asymptomatic hyperuricemia 50 interpersonal psychotherapy IPT 50 extracolonic findings 50 tracheal intubation 50 papillary renal cell carcinoma 50 Glasgow Coma Scale 50 adverse perinatal 50 CTEPH 50 lactate dehydrogenase LDH 50 HIV coinfected 50 angiographically 50 Functional Capacity 50 epilepsy cerebral palsy 50 practitioners internists 50 autosomal dominant inheritance 50 urine albumin 50 physiologic parameters 50 immunizations physicals 50 perinatal complications 50 obstructive sleep 50 tumor subtype 50 dysfunctional voiding 50 Monogram Trofile Assay 50 genomic biomarker 50 probands 50 prospective multicentre 50 microdose 50 anticholinergic agents 50 rEEG ® 50 Corus CAD 50 utero exposure 50 Nonclinical 50 thetreatment 50 including eniluracil ADH 50 psychiatric diagnoses 50 pain catastrophizing 50 covariate 50 adjuvant systemic 50 defibrillator implantation 50 Socioeconomic status 50 genotoxicity studies 50 genotoxicity 50 multicenter clinical trials 50 TQT 50 Acute Myeloid Leukaemia AML 50 psychodynamic therapy 50 cardiac autonomic 50 hyper IgE syndrome 50 metabonomics 50 preeclamptic 50 oral anticoagulation 50 CRLX# 50 leptin deficiency 50 multivariate regression 50 choroidal vasculopathy 50 mean ± SEM 50 PSADT 50 exhaled NO 50 neuropsychiatric symptoms 50 elevated LDH 50 estimated GFR 50 intermittent dosing 50 elective percutaneous coronary 50 BMI percentile 50 overt nephropathy 50 ImmuKnow R 50 Charlson comorbidity index 50 CRp 50 postoperative complication 50 dose escalation phase 50 docetaxel pretreated 50 Creatinine 50 NLSY 50 cytogenetic abnormalities 50 deCODE BreastCancer TM 50 proband 50 comorbid conditions 50 univariate analyzes 50 unresectable tumors 50 Dr. Victor Velculescu 50 QoL 50 living ADLs 50 myocardial viability 50 neurocognitive dysfunction 50 FENO 50 hypothalamic pituitary adrenal axis 50 EuroSCORE 50 airway hyperresponsiveness 50 CC genotype 50 Hemoccult 50 glomerular filtration 50 multivariable logistic regression 50 tissue perfusion 50 positron emission topography 50 dopaminergic therapy 50 serum cortisol 50 cystoscopic 50 symptom severity 50 Positron emission 50 Histopathological 50 ImPACT Immediate Post 50 stratifying patients 50 ICD therapy 50 hemodynamic variables 50 electroencephalograms EEG 50 polyarticular 50 OvaRex MAb 50 substance induced psychosis 50 APOE e4 50 cognitive affective 50 insulin resistance HOMA IR 50 hemoglobin A1c HbA1c 50 Dr. Boustani 50 cognitive functioning 50 differentiate squamous 50 Endothelial function 50 ASCEND HF 50 excretion ADME 50 PARTNER Trial 50 prelicensure 50 Szeinbach 50 Depression Scale 50 functional MRI scans 50 childhood disintegrative disorder 50 Hair follicle 50 Cytogenetic 50 Geriatric Depression 50 inhibitory neurotransmitters 50 tic severity 50 DCE MRI 50 hematological parameters 50 DEXA scan 50 PK PD modeling 50 demonstrated antitumor activity 50 biopsychosocial 50 retrospective cohort study 50 MoxDuo TM IR 50 postoperative AF 50 non pharmacological interventions 50 Vizilite 50 Multivariate analysis revealed 50 oral antidiabetes drugs 50 familial aggregation 50 somatosensory evoked potentials 50 auditory verbal 50 Yurgelun Todd 50 cytologic 50 lesional 50 diabetes mellitus DM 50 EPDS 50 indicates cardio circulatory 50 State Examination MMSE 50 peripartum 50 Montgomery Åsberg Depression 50 EEGs 50 puerperal psychosis 50 Bayley Scales 50 symptomatic VTE 50 linear regression analyzes 50 BenzaClin R 50 serum PTH 50 irregular menses 50 BRCA testing 50 serum estradiol 50 comorbid ADHD 50 NIH CPSI 50 intravascular hemolysis 50 FACIT 50 #mg ATC 50 nerve conduction velocity 50 electroencephalogram 50 RE LY ® 50 methylation markers 50 pharmacodynamic effects 50 Val HeFT 50 fructosamine 50 plasma cortisol 50 serum bicarbonate 50 preimplantation genetic 50 urothelial cancer 50 sleep deprivation impairs 50 Lymph node 50 DBMD 50 inhalation toxicology 50 corrected QT interval 50 cranial irradiation 50 LHRH receptor positive 50 mg kg BID 50 random suspicionless employee 50 Incontinence Impact Questionnaire 50 pre operatively 50 metabolic dysfunction 50 neurologic abnormalities 50 Y BOCS 50 reactogenicity 50 Poisson regression 50 Pfizer reanalyzed 50 anatomical physiological 50 abdominal ultrasound 50 Epworth Sleepiness Scale 50 Rating Scale UPDRS 50 stepwise logistic regression 50 anticholinergic effects 50 electrocardiograms EKGs 50 physiological nutritional 50 vivo pharmacology 50 gynecologic procedures 50 Singh Manoux 50 pulmonary function 50 Social Responsiveness Scale 50 Mild Cognitive Impairment 50 positron emission tomography scans 50 coexisting illnesses 50 impaired glucose metabolism 50 CombAT study 50 F FDG PET 50 hyperlipidaemia 50 pathogenetic mechanisms 50 multivariate Cox 50 multisystemic 50 management biostatistical analysis 50 Prostate specific antigen 50 Depressive symptoms 50 PNH patients 50 hypertension cardiovascular disease 50 ovarian malignancy 50 neurobehavioral functioning 50 Pulsing multicolored diodes 50 transabdominal 50 SEQureDx TM 50 WOMAC scores 50 neuroanatomical 50 tic disorders 50 collected saliva samples 50 ConclusionThis 50 neurobehavioral disorder 50 Ancoli Israel 49 Pain Rating Scale 49 MMSE scores 49 psychometric assessments 49 NOD mouse 49 molecular biomarker 49 vitro dissolution 49 immunochemical fecal occult 49 subtests 49 olanzapine LAI 49 fusion enhancers 49 ADCS ADL 49 recurrent bladder 49 STRIDE PD 49 Phase IIIB IV 49 posttreatment 49 plasma adiponectin 49 serum lipid 49 Kids Inpatient Database 49 coronary computed tomography 49 mg administered orally 49 prospective multicenter study 49 Spirometry 49 MYTHOS trial 49 Depression Inventory 49 laser Doppler 49 Clinical Validation 49 levodopa induced 49 6MWT 49 parasitological 49 sedating medications 49 neuro developmental disorder 49 percutaneous biopsy 49 neuroimaging studies 49 Ecotones Duet 49 depression suicidal ideation 49 warfarin erythromycin 49 Coronary CTA 49 pain palliation 49 fetal malformations 49 inherited metabolic disorders 49 Insulin sensitivity 49 number NCT# ClinicalTrials.gov 49 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 49 Viral load 49 rheumatologic 49 myocardial revascularization 49 neurological exam 49 electrocardiogram EKG 49 pacemaker manufacturer Intrapace 49 electroencephalography EEG 49 inhaled AAT 49 VADT 49 arteries dilate 49 ADME properties 49 clinically asymptomatic 49 hypochondriasis 49 thiopurine 49 www.sanbolic.com 49 summative assessments 49 neurophysiological 49 NT proBNP assay 49 gastroesophageal reflux GERD 49 Calmare pain 49 renal scarring 49 Pharmacokinetic studies 49 Nothing Wadden 49 pelvic ultrasound 49 randomized discontinuation 49 Onko Sure ™ 49 vascular endothelial dysfunction 49 alexithymia 49 airway responsiveness 49 FeNO 49 hepatic lesions 49 Medication adherence 49 prognostic biomarkers 49 fluoxetine Prozac 49 undergo prostate biopsy 49 underwent angiography 49 antiplatelet therapies 49 enzyme immunoassay EIA 49 parkinsonian symptoms 49 NNT = 49 Outcomes Study 49 Elevated triglycerides 49 Prostate Px + 49 elevated TSH 49 schizophrenia CIAS 49 Transcranial Magnetic Stimulation 49 Alternans